IGF2 and major depressive disorder: Decreased levels of a protein upstream of GSK-3, called insulin-like growth factor 2 (IGF2), has previously been implicated in rodent models of depression, with artificial induction of IGF2 expression having protective effects against depressive-like behaviors (156).